TY - JOUR KW - Adolescent KW - Alcohol Drinking/prevention & control KW - Behavior Therapy KW - Child KW - Counseling KW - Health Education KW - Humans KW - Illicit drugs KW - Marijuana Abuse/prevention & control KW - Mass Screening KW - Prescription Drugs KW - Primary Health Care KW - Substance-Related Disorders/diagnosis/prevention & control KW - Tobacco Use/prevention & control KW - Young Adult AU - US Preventive Services Task Force AU - A. H. Krist AU - K. W. Davidson AU - C. M. Mangione AU - M. J. Barry AU - M. Cabana AU - A. B. Caughey AU - K. Donahue AU - C. A. Doubeni AU - J. W. Epling Jr AU - M. Kubik AU - G. Ogedegbe AU - L. Pbert AU - M. Silverstein AU - M. A. Simon AU - C. W. Tseng AU - J. B. Wong A1 - AB - IMPORTANCE: In 2017, an estimated 7.9% of persons aged 12 to 17 years reported illicit drug use in the past month, and an estimated 50% of adolescents in the US had used an illicit drug by the time they graduated from high school. Young adults aged 18 to 25 years have a higher rate of current illicit drug use, with an estimated 23.2% currently using illicit drugs. Illicit drug use is associated with many negative health, social, and economic consequences and is a significant contributor to 3 of the leading causes of death among young persons (aged 10-24 years): unintentional injuries including motor vehicle crashes, suicide, and homicide. OBJECTIVE: To update its 2014 recommendation, the USPSTF commissioned a review of the evidence on the potential benefits and harms of interventions to prevent illicit drug use in children, adolescents, and young adults. POPULATION: This recommendation applies to children (11 years and younger), adolescents (aged 12-17 years), and young adults (aged 18-25 years), including pregnant persons. EVIDENCE ASSESSMENT: Because of limited and inadequate evidence, the USPSTF concludes that the benefits and harms of primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults are uncertain and that the evidence is insufficient to assess the balance of benefits and harms. More research is needed. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care-based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults. (I statement). AD - Fairfax Family Practice Residency, Fairfax, Virginia.; Virginia Commonwealth University, Richmond.; Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.; University of California, Los Angeles.; Harvard Medical School, Boston, Massachusetts.; University of California, San Francisco.; Oregon Health & Science University, Portland.; University of North Carolina at Chapel Hill.; Mayo Clinic, Rochester, Minnesota.; Virginia Tech Carilion School of Medicine, Roanoke.; Temple University, Philadelphia, Pennsylvania.; New York University, New York, New York.; University of Massachusetts Medical School, Worcester.; Boston University, Boston, Massachusetts.; Northwestern University, Evanston, Illinois.; University of Hawaii, Honolulu.; Pacific Health Research and Education Institute, Honolulu, Hawaii.; Tufts University School of Medicine, Boston, Massachusetts. BT - Jama C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use CP - 20 CY - United States DO - 10.1001/jama.2020.6774 IS - 20 JF - Jama LA - eng M1 - Journal Article N2 - IMPORTANCE: In 2017, an estimated 7.9% of persons aged 12 to 17 years reported illicit drug use in the past month, and an estimated 50% of adolescents in the US had used an illicit drug by the time they graduated from high school. Young adults aged 18 to 25 years have a higher rate of current illicit drug use, with an estimated 23.2% currently using illicit drugs. Illicit drug use is associated with many negative health, social, and economic consequences and is a significant contributor to 3 of the leading causes of death among young persons (aged 10-24 years): unintentional injuries including motor vehicle crashes, suicide, and homicide. OBJECTIVE: To update its 2014 recommendation, the USPSTF commissioned a review of the evidence on the potential benefits and harms of interventions to prevent illicit drug use in children, adolescents, and young adults. POPULATION: This recommendation applies to children (11 years and younger), adolescents (aged 12-17 years), and young adults (aged 18-25 years), including pregnant persons. EVIDENCE ASSESSMENT: Because of limited and inadequate evidence, the USPSTF concludes that the benefits and harms of primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults are uncertain and that the evidence is insufficient to assess the balance of benefits and harms. More research is needed. RECOMMENDATION: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care-based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults. (I statement). PP - United States PY - 2020 SN - 1538-3598; 0098-7484 SP - 2060 EP - 2066 EP - T1 - Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement T2 - Jama TI - Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use U2 - 32453374 U3 - 10.1001/jama.2020.6774 VL - 323 VO - 1538-3598; 0098-7484 Y1 - 2020 Y2 - May 26 ER -